Promoting meaningful clinical trial outcome measures for Duchenne muscular dystrophy

H. Peav; A. Kennedy; R. Fischer; A. Bronson; P. Furlong

doi:doi:10.1016/j.nmd.2016.06.366

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Promoting meaningful clinical trial outcome measures for Duchenne muscular dystrophy

Peav, H., Kennedy, A., Fischer, R., Bronson, A., & Furlong, P. (2016). Promoting meaningful clinical trial outcome measures for Duchenne muscular dystrophy. Neuromuscular Disorders, 26(S2), S187-S187. https://doi.org/10.1016/j.nmd.2016.06.366

Copy citation

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Article

Development of a novel shared decision making aid for primary immunodeficiency diseases

Article

Community overdose surveillance

Article

Promoting meaningful clinical trial outcome measures for Duchenne muscular dystrophy

Publications Info

Recent Publications

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Development of a novel shared decision making aid for primary immunodeficiency diseases

Community overdose surveillance

Epigenetic biomarkers for smoking cessation

Partner With Us

Site